Koyfin Home > Directory > Health Care > Biogen Inc > Cost of Goods Sold

Biogen Inc Cost of Goods Sold Chart (BIIB)

Biogen Inc annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Biogen Inc Cost of Goods Sold for the quarter ending September 09, 2020 was $449m a 0.45% increase of 2m year over year
  • Biogen Inc Cost of Goods Sold for the last 12 months ending September 09, 2020 was $1,762m a -11.00% decrease of -194m year over year
  • Biogen Inc Annual Cost of Goods Sold for 2019 was $1,955m a 7.11% increase of 139m from 2018
  • Biogen Inc Annual Cost of Goods Sold for 2018 was $1,816m a 10.26% increase of 186m from 2017
  • Biogen Inc Annual Cost of Goods Sold for 2017 was $1,630m a 12.07% increase of 197m from 2016
Other Income Statement Metrics:
  • Biogen Inc EBITDA for the quarter ending December 12, 2018 was $1,738m a -0.80% decrease of -14m year over year
  • Biogen Inc Net Income for the quarter ending December 12, 2018 was $947m a -23.88% decrease of -226m year over year
  • Biogen Inc Total Revenue for the quarter ending December 12, 2018 was $3,526m a 11.21% increase of 395m year over year
View Chart On Koyfin

Quarterly BIIB Cost of Goods Sold Data

09/2020$449m
06/2020$411m
03/2020$454m
12/2019$447m
09/2019$430m
06/2019$476m
03/2019$602m
12/2018$489m
09/2018$461m
06/2018$421m

Annual BIIB Cost of Goods Sold Data

2019$1,955m
2018$1,816m
2017$1,630m
2016$1,433m
2015$1,240m
2014$1,171m
2013$858m
2012$545m
2011$467m
2010$394m